Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states

References

• GreenwaldDAProtein-losing gastroenteropathyFeldmanMFriedmanLSBrandtLJSleisenger and Fordtran’s Gastrointestinal and Liver Disease110th edPhiladelphia, PASaunders2016464470
   Google Scholar
• LevittDGLevittMDHuman serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurementsInt J Gen Med2016922925527486341
   PubMed Web of Science ®Google Scholar
• FulksMStoutRLDolanVFAlbumin and all-cause mortality risk in insurance applicantsJ Insur Med2010421111721290995
   PubMedGoogle Scholar
• SchomerusHMayerGSynthesis rates of albumin and fibrinogen in patients with protein-losing enteropathy and in a patient recovering from protein malnutritionDigestion1975134201208812754
   PubMed Web of Science ®Google Scholar
• WaldmannTASteinfeldJLDutcherTFDavidsonJDGordonRSJrThe role of the gastrointestinal system in “idiopathic hypoproteinemia”Gastroenterology19614119720713782654
   PubMed Web of Science ®Google Scholar
• WochnerRDWeissmanSMWaldmannTAHoustonDBerlinNIDirect measurement of the rates of synthesis of plasma proteins in control subjects and patients with gastrointestinal protein lossJ Clin Invest19684759719825239039
   PubMed Web of Science ®Google Scholar
• AndersenSBRossingNMetabolism of albumin and gammaG-globulin during albumin infusions and during plasmapheresisScand J Clin Lab Invest1967202183184
   Web of Science ®Google Scholar
• BennholdHKalleeEComparative studies on the half-life of I 131-labeled albumins and nonradioactive human serum albumin in a case of analbuminemiaJ Clin Invest195938586387213654522
   PubMed Web of Science ®Google Scholar
• FreemanTGordonAHAlbumin catabolism in hypoproteinaemic states studies with 131-I-albuminBibl Haematol196523110811155894593
   PubMedGoogle Scholar
• RoopenianDCLowBEChristiansonGJProetzelGSprouleTJWilesMVAlbumin-deficient mouse models for studying metabolism of human albumin and pharmacokinetics of albumin-based drugsMAbs20157234435125654695
   PubMed Web of Science ®Google Scholar
• SteinfeldJLDavidsonJDGordonRSJrGreeneFEThe mechanism of hypoproteinemia in patients with regional enteritis and ulcerative colitisAm J Med19602940541513834226
   PubMed Web of Science ®Google Scholar
• van TongerenJHMajoorCLDemonstration of protein-losing gastroenteropathy. The disappearance rate of 51Cr from plasma and the binding of 51Cr to different serum proteinsClin Chim Acta196614131415958730
   PubMed Web of Science ®Google Scholar
• WaldmannTAGastrointestinal protein loss demonstrated by Cr-51-labeled albuminLancet19612719412112313782655
   PubMed Web of Science ®Google Scholar
• KerrRMDu BoisJJHoltPRUse of 125-I- and 51-Cr-labeled albumin for the measurement of gastrointestinal and total albumin catabolismJ Clin Invest19674612206420825630419
   PubMed Web of Science ®Google Scholar
• WaldmannTAWochnerRDStroberWThe role of the gastrointestinal tract in plasma protein metabolism. Studies with 51Cr-albuminAm J Med19694622752854886918
   PubMed Web of Science ®Google Scholar
• BernierJJFlorentCDesmazuresCAymesCL’HirondelCDiagnosis of protein-losing enteropathy by gastrointestinal clearance of alpha1-antitrypsinLancet19782809376376480688
   PubMed Web of Science ®Google Scholar
• QuigleyEMRossINHaeneyMRHolbrookIBMarshMNReassessment of fecal alpha-1-antitrypsin excretion for use as screening test for intestinal protein lossJ Clin Pathol198740161663493263
   PubMed Web of Science ®Google Scholar
• BaiJCSambuelliANiveloniSAlpha 1-antitrypsin clearance as an aid in the management of patients with celiac diseaseAm J Gastroenterol19918689869911858765
   PubMed Web of Science ®Google Scholar
• KarbachUEweKBodensteinHAlpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn’s diseaseGut19832487187236603392
   PubMed Web of Science ®Google Scholar
• StryglerBNicarMJSantangeloWCPorterJLFordtranJSAlpha 1-antitrypsin excretion in stool in normal subjects and in patients with gastrointestinal disordersGastroenterology1990995138013872210245
   PubMed Web of Science ®Google Scholar
• FlorentCL’HirondelCDesmazuresCAymesCBernierJJIntestinal clearance of alpha 1-antitrypsin. A sensitive method for the detection of protein-losing enteropathyGastroenterology19818147777806973500
   PubMed Web of Science ®Google Scholar
• FlorentCVidonNFlourieBGastric clearance of alpha-1-antitrypsin under cimetidine perfusion. New test to detect protein-losing gastropathy?Dig Dis Sci198631112153484447
   PubMed Web of Science ®Google Scholar
• ChauTNMokMYChanEYEvaluation of performance of measurement of fecal alpha(1)-antitrypsin clearance and technetium-99m human serum albumin scintigraphy in protein-losing enteropathyDigestion201184319920621757911
   PubMed Web of Science ®Google Scholar
• KhalesiMNakhaeiAASeyedAJDiagnostic accuracy of nuclear medicine imaging in protein losing enteropathy: systematic review and meta-analysis of the literatureActa Gastroenterol Belg201376441342224592545
   PubMed Web of Science ®Google Scholar
• WilsonJPSurface area of the small intestine in manGut1967866186215625041
   PubMed Web of Science ®Google Scholar
• WatsonAJChuSSieckLEpithelial barrier function in vivo is sustained despite gaps in epithelial layersGastroenterology2005129390291216143130
   PubMed Web of Science ®Google Scholar
• RavinHASeligmanAMFineJPolyvinyl pyrrolidone as a plasma expander; studies on its excretion, distribution and metabolismN Engl J Med19522472492192913002648
   PubMed Web of Science ®Google Scholar
• KeulemansYCMokKSde WitLTGoumaDJGroenAKHepatic bile versus gallbladder bile: a comparison of protein and lipid concentration and composition in cholesterol gallstone patientsHepatology199828111169657090
   PubMed Web of Science ®Google Scholar
• MullockBMShawLJFitzharrisBSources of proteins in human bileGut19852655005093996941
   PubMed Web of Science ®Google Scholar
• BoyerJLBloomerJRCanalicular bile secretion in man. Studies utilizing the biliary clearance of (14C)mannitolJ Clin Invest19745447737814610005
   PubMed Web of Science ®Google Scholar
• MultignerLFigarellaCSahelJSarlesHLactoferrin and albumin in human pancreatic juice: a valuable test for diagnosis of pancreatic diseasesDig Dis Sci19802531731786768533
   PubMed Web of Science ®Google Scholar
• HayakawaTHaradaHNodaAKondoTLactoferrin in pure pancreatic juice in chronic pancreatitisAm J Gastroenterol19837842222246837546
   PubMed Web of Science ®Google Scholar
• VignesSBellangerJPrimary intestinal lymphangiectasia (Waldmann’s disease)Orphanet J Rare Dis20083518294365
   PubMed Web of Science ®Google Scholar
• TakenakaHOhmiyaNHirookaYEndoscopic and imaging findings in protein-losing enteropathyJ Clin Gastroenterol201246757558022138845
   PubMed Web of Science ®Google Scholar
• AoyagiKIidaMYaoTMatsuiTOkadaMFujishimaMIntestinal lymphangiectasia: value of double-contrast radiographic studyClin Radiol199449118148197955851
   PubMed Web of Science ®Google Scholar
• SalomonsHAKramerPNikulassonSSchroyPCEndoscopic features of long-standing primary intestinal lymphangiectasiaGastrointest Endosc19954155165187615236
   PubMed Web of Science ®Google Scholar
• StoelingaGBvanMJSlooffJPChylous effusions into the intestine in a patient with protein-losing gastroenteropathyPediatrics1963311011101813984247
   PubMed Web of Science ®Google Scholar
• MistilisSPSkyringAPStephenDDIntestinal Lymphangiectasia Mechanism of Enteric Loss of Plasma-Protein and FatLancet196517376777914234205
   PubMed Web of Science ®Google Scholar
• SoYChungJKSeoJKDifferent patterns of lymphoscintigraphic findings in patients with intestinal lymphangiectasiaNucl Med Commun200122111249125411606892
   PubMed Web of Science ®Google Scholar
• SoucyJPEybalinMCTailleferRLevasseurAJobinGLymphoscintigraphic demonstration of intestinal lymphangiectasiaClin Nucl Med19838115355376653008
   PubMed Web of Science ®Google Scholar
• GoldRHYoukerJEIdiopathic intestinal lymphangiectasis (primary protein-losing enteropathy). Lymphographic verification of enteric and peritoneal leakage of chyleRadiology197310923513524355068
   PubMed Web of Science ®Google Scholar
• DesaiAPGuvencBHCarachiREvidence for medium chain triglycerides in the treatment of primary intestinal lymphangiectasiaEur J Pediatr Surg200919424124519449286
   PubMed Web of Science ®Google Scholar
• LaiYYuTQiaoXYZhaoLNChenQKPrimary intestinal lymphangiectasia diagnosed by double-balloon enteroscopy and treated by medium-chain triglycerides: a case reportJ Med Case Rep201371923316917
   PubMedGoogle Scholar
• MeijersBKSchallaSEerensFProtein-losing enteropathy in association with constrictive pericarditisInt J Cardiovasc Imaging2006223–438939216502021
   PubMed Web of Science ®Google Scholar
• NelsonDLBlaeseRMStroberWBruceRWaldmannTAConstrictive pericarditis, intestinal lymphangiectasia, and reversible immunologic deficiencyJ Pediatr19758645485541127501
   PubMed Web of Science ®Google Scholar
• PetersenVPHastrupJProtein-losing enteropathy in constrictive pericarditisActa Med Scand196317340141013942764
   PubMedGoogle Scholar
• WilkinsonPPintoBSeniorJRReversible protein-losing enteropathy with intestinal lymphangiectasia secondary to chronic constrictive pericarditisN Engl J Med196527322117811815847556
   PubMed Web of Science ®Google Scholar
• JohnsonJNDriscollDJO’LearyPWProtein-losing enteropathy and the Fontan operationNutr Clin Pract201227337538422516942
   PubMed Web of Science ®Google Scholar
• SchumacherKRStringerKADonohueJESocial media methods for studying rare diseasesPediatrics20141335e1345e135324733869
   PubMed Web of Science ®Google Scholar
• JohnASJohnsonJAKhanMDriscollDJWarnesCACettaFClinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operationJ Am Coll Cardiol2014641546224998129
   PubMed Web of Science ®Google Scholar
• MertensLHaglerDJSauerUSomervilleJGewilligMProtein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study groupJ Thorac Cardiovasc Surg19981155106310739605076
   PubMed Web of Science ®Google Scholar
• RychikJProtein-losing enteropathy after Fontan operationCongenit Heart Dis20072528830018377444
   PubMedGoogle Scholar
• MagdoHSStillwellTLGreenhawtMJImmune abnormalities in Fontan protein-losing enteropathy: a case-control studyJ Pediatr2015167233133726009017
   PubMed Web of Science ®Google Scholar
• MeadowsJJenkinsKProtein-losing enteropathy: integrating a new disease paradigm into recommendations for prevention and treatmentCardiol Young201121436337721349233
   PubMed Web of Science ®Google Scholar
• AntonioMGordoAPereiraCPintoFFragataIFragataJThoracic duct decompression for protein-losing enteropathy in failing Fontan circulationAnn Thorac Surg201610162370237327211948
   PubMed Web of Science ®Google Scholar
• ConnorFLAngelidesSGibsonMSuccessful resection of localized intestinal lymphangiectasia post-Fontan: role of (99m)technetium-dextran scintigraphyPediatrics20031123 Pt 1e242e24712949320
   PubMed Web of Science ®Google Scholar
• LinWSHwangMSChungHTProtein-losing enteropathy after the Fontan operation: clinical analysis of nine casesChang Gung Med J200629550551217214396
   PubMedGoogle Scholar
• OhuchiHYasudaKMiyazakiAHemodynamic characteristics before and after the onset of protein losing enteropathy in patients after the Fontan operationEur J Cardiothorac Surg2013433e49e5723396878
   PubMed Web of Science ®Google Scholar
• LenzDHambschJSchneiderPProtein-losing enteropathy in patients with Fontan circulation: is it triggered by infection?Crit Care20037218519012720566
   PubMed Web of Science ®Google Scholar
• RyersonLGoldbergCRosenthalAArmstrongAUsefulness of heparin therapy in protein-losing enteropathy associated with single ventricle palliationAm J Cardiol2008101224825118178416
   PubMed Web of Science ®Google Scholar
• DavisCADriscollDJPerraultJEnteric protein loss after the Fontan operationMayo Clin Proc19946921121148309260
   PubMed Web of Science ®Google Scholar
• FujiiTShimizuTTakahashiKFecal alpha1-antitrypsin concentrations as a measure of enteric protein loss after modified Fontan operationsJ Pediatr Gastroenterol Nutr200337557758014581800
   PubMed Web of Science ®Google Scholar
• ThorneSAHooperJKempMSomervilleJGastro-intestinal protein loss in late survivors of Fontan surgery and other congenital heart diseaseEur Heart J19981935145209568457
   PubMed Web of Science ®Google Scholar
• OstrowAMFreezeHRychikJProtein-losing enteropathy after Fontan operation: investigations into possible pathophysiologic mechanismsAnn Thorac Surg200682269570016863787
   PubMed Web of Science ®Google Scholar
• ChanFKSungJJMaKMLeungYLYeungVTProtein-losing enteropathy in congestive heart failure: diagnosis by means of a simple methodHepatogastroenterology199946271816181810430351
   PubMedGoogle Scholar
• BerkowitzISegalIProtein-losing enteropathy in congestive cardiac failure: an entity of minor clinical significanceAm J Gastroenterol19908521541562301337
   PubMed Web of Science ®Google Scholar
• DumontAEMulhollandJHAlterations in thoracic duct lymph flow in hepatic cirrhosis: significance in portal hypertensionAnn Surg1962156466867517859709
   PubMed Web of Science ®Google Scholar
• StanleyAJGilmourHMGhoshSFergusonAMcGilchristAJTransjugular intrahepatic portosystemic shunt as a treatment for protein-losing enteropathy caused by portal hypertensionGastroenterology19961116167916828942750
   PubMed Web of Science ®Google Scholar
• WongWMHuiCKYuenMFReversal of protein-losing enteropathy by liver transplantationJ Clin Gastroenterol20033618687
   Web of Science ®Google Scholar
• GeorgopoulosPMowatCMcMillanDCKingstoneKGhoshSStanleyAJIs portal hypertension associated with protein-losing enteropathy?J Gastroenterol Hepatol200520110310715610454
   PubMed Web of Science ®Google Scholar
• DavcevPVanovskiBSestakovDTadzerIProtein-losing enteropathy in patients with liver cirrhosisDigestion19692117225776462
   PubMed Web of Science ®Google Scholar
• FussIJStroberWCuccheriniBAIntestinal lymphangiectasia, a disease characterized by selective loss of naive CD45RA + lymphocytes into the gastrointestinal tractEur J Immunol19982812427542859862365
   PubMed Web of Science ®Google Scholar
• MullerCWolfHGottlicherJZielinskiCCEiblMMCellular immunodeficiency in protein-losing enteropathy. Predominant reduction of CD3+ and CD4+ lymphocytesDig Dis Sci19913611161221670632
   PubMed Web of Science ®Google Scholar
• BendixenGJarnumSSoltoftJWestergaardHWeekeBYssingMIgG and albumin turnover in Crohn’s diseaseScand J Gastroenterol1968354814894179645
   PubMed Web of Science ®Google Scholar
• BehKJWatsonDLLascellesAKConcentrations of immunoglobulins and albumin in lymph collected from various regions of the body of the sheepAust J Exp Biol Med Sci197452181864208059
   PubMedGoogle Scholar
• VaermanJPHeremansJFOrigin and molecular size of immunoglobulin-A in the mesenteric lymph of the dogImmunology197018127384983521
   PubMed Web of Science ®Google Scholar
• SandsBESiegelCACrohn’s DiseaseFeldmanMFriedmanANBrandtLJSleisenger and Fordtran’s Gastroinstestinal and Liver Disease210th edSaunders201619902022
   Google Scholar
• DubcencoEJeejeebhoyKNPetronieneRCapsule endoscopy findings in patients with established and suspected small-bowel Crohn’s disease: correlation with radiologic, endoscopic, and histologic findingsGastrointest Endosc200562453854416185968
   PubMed Web of Science ®Google Scholar
• CourticeFCSimmondsWJSteinbeckAWSome investigations of lymph from a thoracic duct fistula in manAust J Exp Biol Med Sci19512920121014869281
   PubMedGoogle Scholar
• FanousMYPhillipsAJWindsorJAMesenteric lymph: the bridge to future management of critical illnessJOP20078437439917625290
   PubMedGoogle Scholar
• BillAPlasma protein dynamics: albumin and IgG capillary permeability, extravascular movement and regional blood flow in unanesthetized rabbitsActa Physiol Scand197710112842906860
   PubMedGoogle Scholar
• KinghamJGLoehryCASelectivity of small intestinal exudate in celiac disease and Crohn’s diseaseAm J Dig Dis19782313338619623
   PubMedGoogle Scholar
• OlaisonGLeanderssonPSjodahlRTagessonCIntestinal permeability to polyethyleneglycol 600 in Crohn’s disease. Peroperative determination in a defined segment of the small intestineGut19882921961993345930
   PubMed Web of Science ®Google Scholar
• AinsworthMEriksenJRasmussenJWSchaffalitzky de MuckadellOBIntestinal permeability of 51Cr-labeled ethylenediaminetetraacetic acid in patients with Crohn’s disease and their healthy relativesScand J Gastroenterol19892489939982512633
   PubMed Web of Science ®Google Scholar
• MikiKMooreDJButlerRNSouthcottECouperRTDavidsonGPThe sugar permeability test reflects disease activity in children and adolescents with inflammatory bowel diseaseJ Pediatr199813367507549842038
   PubMed Web of Science ®Google Scholar
• MurphyMSEasthamEJNelsonRPearsonADLakerMFIntestinal permeability in Crohn’s diseaseArch Dis Child19896433213252495775
   PubMed Web of Science ®Google Scholar
• AlexanderJSChaitanyaGVGrishamMBBoktorMEmerging roles of lymphatics in inflammatory bowel diseaseAnn N Y Acad Sci20101207Suppl 1E75E8520961310
   PubMed Web of Science ®Google Scholar
• Van KruiningenHJColombelJFThe forgotten role of lymphangitis in Crohn’s diseaseGut20085711418094195
   PubMed Web of Science ®Google Scholar
• von der WeidPYRehalSFerrazJGRole of the lymphatic system in the pathogenesis of Crohn’s diseaseCurr Opin Gastroenterol201127433534121543977
   PubMed Web of Science ®Google Scholar
• Garcia de TenaJManzanoLLealJCSan AntonioESualdeaVAlvarez-MonMActive Crohn’s disease patients show a distinctive expansion of circulating memory CD4+ CD45RO + CD28null T cellsJ Clin Immunol200424218519615024186
   PubMed Web of Science ®Google Scholar
• KellyCPCeliac DiseaseFeldmanMFriedmanLSBrandtLJSleisenger and Fordtran’s Gastrointestinal and Liver Disease2Philadelphia, PASaunders201618491872
   Google Scholar
• StenhammarLFalth-MagnussonKJanssonGMagnussonKESundqvistTIntestinal permeability to inert sugars and different-sized polyethyleneglycols in children with celiac diseaseJ Pediatr Gastroenterol Nutr1989932812892614613
   PubMed Web of Science ®Google Scholar
• LasterLWaldmannTAFensterLFSingletonJWAlbumin metabolism in patients with Whipple’s diseaseJ Clin Invest19664556376444160668
   PubMed Web of Science ®Google Scholar
• MaiwaldMHerbayAVWhipple’s DiseaseFeldmanMFriedmanLSBrandtLJSleisenger and Fordtran Gastrointestinal and Liver Disease210th edPhiladelphia, PASaunders201618861895
   Google Scholar
• BennerKGMontanaroAProtein-losing enteropathy in systemic lupus erythematosus. Diagnosis and monitoring immunosuppressive therapy by alpha-1-antitrypsin clearance in stoolDig Dis Sci19893411321352783407
   PubMed Web of Science ®Google Scholar
• ZhengWJTianXPLiLProtein-losing enteropathy in systemic lupus erythematosus: analysis of the clinical features of fifteen patientsJ Clin Rheumatol200713631331618176138
   PubMed Web of Science ®Google Scholar
• MoosVSchmidtCGeelhaarAImpaired immune functions of monocytes and macrophages in Whipple’s diseaseGastroenterology2010138121022019664628
   PubMed Web of Science ®Google Scholar
• MarthTRouxMvon HerbayAMeuerSCFeurleGEPersistent reduction of complement receptor 3 alpha-chain expressing mononuclear blood cells and transient inhibitory serum factors in Whipple’s diseaseClin Immunol Immunopathol19947222172267519533
   PubMedGoogle Scholar
• HabibagahiMHabibagahiZJaberipourMAghdashiAQuantification of regulatory T cells in peripheral blood of patients with systemic lupus erythematosusRheumatol Int20113191219122520361330
   PubMed Web of Science ®Google Scholar
• ClayburghDRShenLTurnerJRA porous defense: the leaky epithelial barrier in intestinal diseaseLab Invest200484328229114767487
   PubMed Web of Science ®Google Scholar
• SchulzkeJDBentzelCJSchulzkeIRieckenEOFrommMEpithelial tight junction structure in the jejunum of children with acute and treated celiac spruePediatr Res1998434 Pt 14354419544995
   PubMed Web of Science ®Google Scholar
• MadaraJLTrierJSStructural abnormalities of jejunal epithelial cell membranes in celiac sprueLab Invest19804332542617401635
   PubMed Web of Science ®Google Scholar
• CitrinYSterlingKHalstedJAThe mechanism of hypoproteinemia associated with giant hypertrophy of the gastric mucosaN Engl J Med19572571990691213477410
   PubMed Web of Science ®Google Scholar
• AzerMSultanAZalataKAbd El-HaleemIHassanAEl-EbeidyGA case of Menetrier’s disease without Helicobacter pylori or hypoalbuminemiaInt J Surg Case Rep201517586026551554
   PubMedGoogle Scholar
• MeuwissenSGRidwanBUHasperHJInnemeeGHypertrophic protein-losing gastropathy. A retrospective analysis of 40 cases in The Netherlands. The Dutch Menetrier Study GroupScand J Gastroenterol Suppl199219417
   PubMedGoogle Scholar
• XiongLSGongYYNatural history of adult-onset Menetrier’s disease: report of a case with 9-year follow-upExp Ther Med20161162462246627284333
   PubMed Web of Science ®Google Scholar
• BurdickJSChungETannerGTreatment of Menetrier’s disease with a monoclonal antibody against the epidermal growth factor receptorN Engl J Med2000343231697170111106719
   PubMed Web of Science ®Google Scholar
• FiskeWHTanksleyJNamKTEfficacy of cetuximab in the treatment of Menetrier’s diseaseSci Transl Med2009188ra18
   Web of Science ®Google Scholar
• WilliamsonKParkHKSchachtRKaisthaAA case of menetrier disease in a childPediatr Emerg Care201228327727922391924
   PubMed Web of Science ®Google Scholar
• JarnumSJensenKBPlasma protein turnover (albumin, transfer-rin, IgG, IgM) in Menetrier’s disease (giant hypertrophic gastritis): evidence of non-selective protein lossGut19721321281375045705
   PubMed Web of Science ®Google Scholar
• ReinhartWHWeigandKKappelerMRoeslerHHalterFComparison of gastrointestinal loss of alpha-1-antitrypsin and chromium-51-albumin in Menetrier’s disease and the influence of ranitidineDigestion19832641921966307792
   PubMed Web of Science ®Google Scholar
• HuhWJCoffeyRJWashingtonMKMenetrier’s disease: its mimickers and pathogenesisJ Pathol Transl Med2016501101626689786
   PubMedGoogle Scholar
• TakagiHJhappanCSharpRMerlinoGHypertrophic gastropathy resembling Menetrier’s disease in transgenic mice overexpressing transforming growth factor alpha in the stomachJ Clin Invest1992903116111671522224
   PubMed Web of Science ®Google Scholar
• MiuraSAsakuraHTsuchiyaMLymphatic abnormalities in protein-losing gastropathy, especially in Menetrier’s diseaseAngiology19813253453547235306
   PubMed Web of Science ®Google Scholar
• OderdaGCintiSCangiottiAMForniMAnsaldiNIncreased tight junction width in two children with Menetrier’s diseaseJ Pediatr Gastroenterol Nutr19901111231272167358
   PubMed Web of Science ®Google Scholar
• KellyDGMillerLJMalageladaJRHuizengaKAMarkowitzHGiant hypertrophic gastropathy (Menetrier’s disease): pharmacologic effects on protein leakage and mucosal ultrastructureGastroenterology19828335815896124476
   PubMed Web of Science ®Google Scholar
• BecheurHPauwelsAMostefa-KaraNGastric protein loss and alcoholic cirrhosis. Study by measurement of gastric clearance of alpha 1-antitrypsinGastroenterol Clin Biol1996208–96696738977815
   PubMedGoogle Scholar
• DonnellyJPRosenthalACastleVPHolmesRDReversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliationJ Pediatr199713034744789063428
   PubMed Web of Science ®Google Scholar
• AngYSMahmudNWhiteBRandomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel diseaseAliment Pharmacol Ther20001481015102210930895
   PubMed Web of Science ®Google Scholar
• FolwacznyCWiebeckeBLoeschkeKUnfractioned heparin in the therapy of patients with highly active inflammatory bowel diseaseAm J Gastroenterol19999461551155510364024
   PubMed Web of Science ®Google Scholar
• ChandeNMacDonaldJKWangJJMcDonaldJWUnfractionated or low molecular weight heparin for induction of remission in ulcerative colitis: a Cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trialsInflamm Bowel Dis20111791979198621618363
   PubMed Web of Science ®Google Scholar
• BodeLSalvestriniCParkPWHeparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier functionJ Clin Invest2008118122923818064305
   PubMed Web of Science ®Google Scholar
• MurchSHWinyardPJKoletzkoSCongenital enterocyte heparan sulphate deficiency with massive albumin loss, secretory diarrhea, and malnutritionLancet19963479011129913018622507
   PubMed Web of Science ®Google Scholar
• WangZLiRTanJSyndecan-1 acts in synergy with tight junction through stat3 signaling to maintain intestinal mucosal barrier and prevent bacterial translocationInflamm Bowel Dis20152181894190725970544
   PubMed Web of Science ®Google Scholar
• MullerTHessMWSchiefermeierNMYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarityNat Genet200840101163116518724368
   PubMed Web of Science ®Google Scholar
• ThoeniCAmirAGuoCA novel nonsense mutation in the EpCAM gene in a patient with congenital tufting enteropathyJ Pediatr Gastroenterol Nutr2014581182124048167
   PubMed Web of Science ®Google Scholar
• StephenJVilbouxTHabermanYCongenital protein losing enteropathy: an inborn error of lipid metabolism due to DGAT1 mutationsEur J Hum Genet20162491268127326883093
   PubMed Web of Science ®Google Scholar
• ElkadriAThoeniCDeharvengtSJMutations in plasmalemma vesicle associated protein result in sieving protein-losing enteropathy characterized by hypoproteinemia, hypoalbuminemia, and hypertriglyceridemiaCell Mol Gastroenterol Hepatol201514381394 e38726207260
   PubMed Web of Science ®Google Scholar
• HoffmannJCPawlowskiNNKuhlAAHohneWZeitzMAnimal models of inflammatory bowel disease: an overviewPathobiology200270312113012571415
   PubMed Web of Science ®Google Scholar
• MatriconJMeleineMGelotAReview article: Associations between immune activation, intestinal permeability and the irritable bowel syndromeAliment Pharmacol Ther20123611–121009103123066886
   PubMed Web of Science ®Google Scholar
• FischbachWBeckerWMossnerJKochWReinersCFecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseasesGut19872843863933495470
   PubMed Web of Science ®Google Scholar
• BianconeLFantiniMTostiCBozziRVavassoriPPalloneFFecal alpha 1-antitrypsin clearance as a marker of clinical relapse in patients with Crohn’s disease of the distal ileumEur J Gastroenterol Hepatol200315326126612610321
   PubMed Web of Science ®Google Scholar
• KlotzUTemlASchwabMClinical pharmacokinetics and use of infliximabClin Pharmacokinet200746864566017655372
   PubMed Web of Science ®Google Scholar
• BrandseJFvan den BrinkGRWildenbergMELoss of infliximab into feces is associated with lack of response to therapy in patients with severe ulcerative colitisGastroenterology20151492350355 e35225917786
   PubMed Web of Science ®Google Scholar